Receptor binding and cellular uptake studies of macrophage migration inhibitory factor (MIF): use of biologically active labeled MIF derivatives
- PMID: 12034043
- DOI: 10.1089/107999002753675785
Receptor binding and cellular uptake studies of macrophage migration inhibitory factor (MIF): use of biologically active labeled MIF derivatives
Abstract
Macrophage migration inhibitory factor (MIF) is a pleiotropic cytokine for which a receptor has not been identified. That MIF has intracellular functions has been suggested by its enzymatic activity and constitutive expression profile. The discovery of functional MIF-c-Jun activation domain binding protein 1 (JAB1) binding has confirmed this notion and indicated that nonreceptor-based signaling mechanisms are important for MIF function. Here, we have generated and tested several biologically active labeled MIF derivatives to further define target protein binding by MIF and its cellular uptake characteristics. (35)S-MIF, biotinylated MIF, and fluoresceinated MIF were demonstrated to exhibit full biologic activity. Neither by applying a standard iodinated MIF preparation nor by using the biologically active (35)S-MIF derivative in receptor-binding studies were we able to measure any receptor-binding activity on numerous cells, confirming that uptake of MIF into target cells and MIF signaling can occur by receptor-independent pathways. When MIF derivatives were applied in cellular uptake studies, MIF was found to be endocytosed into both immune and nonimmune cells and targeted to the cytosol and lysosomes. The entry of MIF was temperature and energy dependent and was inhibited by monodansylcadaverine but not by ouabain. Endocytosed biotin-MIF bound JAB1 not only in macrophages, as shown previously, but also in nonimmune cells. A tagged MIF construct, MIF-enhanced green fluorescent protein (EGFP), was shown to be a valuable tool, as EGFP constructs of critical MIF cysteine mutants exhibited identical cellular localization properties to those of wild-type MIF (wtMIF). Our results indicate that MIF membrane receptors are not widely expressed, if at all, and suggest that the cellular uptake of MIF occurs by nonreceptor-mediated endocytosis rather than penetration. All the derivatives investigated, except for iodinated MIF, represent valuable tools for further MIF target protein and cellular studies.
Similar articles
-
Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1.Nature. 2000 Nov 9;408(6809):211-6. doi: 10.1038/35041591. Nature. 2000. PMID: 11089976
-
Macrophage migration inhibitory factor does not modulate co-activation of androgen receptor by Jab1/CSN5.Mol Cell Biochem. 2008 Jan;307(1-2):265-71. doi: 10.1007/s11010-007-9578-3. Epub 2007 Sep 5. Mol Cell Biochem. 2008. PMID: 17786542
-
Binding of JAB1/CSN5 to MIF is mediated by the MPN domain but is independent of the JAMM motif.FEBS Lett. 2005 Mar 14;579(7):1693-701. doi: 10.1016/j.febslet.2005.01.080. FEBS Lett. 2005. PMID: 15757663
-
Macrophage migration inhibitory factor: molecular, cellular and genetic aspects of a key neuroendocrine molecule.J Endocrinol. 2004 Jul;182(1):1-9. doi: 10.1677/joe.0.1820001. J Endocrinol. 2004. PMID: 15225126 Review.
-
Glucocorticoid counter regulation: macrophage migration inhibitory factor as a target for drug discovery.Curr Opin Pharmacol. 2001 Dec;1(6):662-8. doi: 10.1016/s1471-4892(01)00112-6. Curr Opin Pharmacol. 2001. PMID: 11757824 Review.
Cited by
-
Macrophage migration inhibitory factor: a potential therapeutic target for rheumatoid arthritis.Korean J Intern Med. 2016 Jul;31(4):634-42. doi: 10.3904/kjim.2016.098. Epub 2016 May 12. Korean J Intern Med. 2016. PMID: 27169879 Free PMC article. Review.
-
Macrophage migration inhibitory factor promotes cell death and aggravates neurologic deficits after experimental stroke.J Cereb Blood Flow Metab. 2011 Apr;31(4):1093-106. doi: 10.1038/jcbfm.2010.194. Epub 2010 Nov 10. J Cereb Blood Flow Metab. 2011. PMID: 21063426 Free PMC article.
-
Role of Myeloma-Derived MIF in Myeloma Cell Adhesion to Bone Marrow and Chemotherapy Response.J Natl Cancer Inst. 2016 Jul 5;108(11):djw131. doi: 10.1093/jnci/djw131. Print 2016 Nov. J Natl Cancer Inst. 2016. PMID: 27381622 Free PMC article.
-
Cytokines and atherosclerosis: a comprehensive review of studies in mice.Cardiovasc Res. 2008 Aug 1;79(3):360-76. doi: 10.1093/cvr/cvn120. Epub 2008 May 16. Cardiovasc Res. 2008. PMID: 18487233 Free PMC article. Review.
-
Cytochalasin B Treatment and Osmotic Pressure Enhance the Production of Extracellular Vesicles (EVs) with Improved Drug Loading Capacity.Nanomaterials (Basel). 2021 Dec 21;12(1):3. doi: 10.3390/nano12010003. Nanomaterials (Basel). 2021. PMID: 35009953 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous